BLCO · Insider Trading
Bausch + Lomb Corporation
Every open-market purchase and sale reported by BLCO officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | Laurence E Paul | Director | A | +11,776 | — |
| 2026-08-14 | Barbara Trebbi | Director | A | +11,776 | — |
| 2026-08-14 | Robert J Chersi | Director | A | +11,776 | — |
| 2026-08-12 | Frederick Munsch | SVP, Controller and CAO | Sell | −52,900 | −$887.66K |
| 2026-08-10 | Andrew C. Von Eschenbach | Director | Sell | −18,559 | −$306.71K |
| 2026-08-07 | Andrew J. Stewart | President, GPIC | A | +16,778 | — |
| 2026-08-07 | Frederick Munsch | SVP, Controller and CAO | A | +9,091 | — |
| 2026-08-07 | Brent L Saunders | Chairman of the Board and CEO | MIXED | +277,648 | −$70.91K |
| 2026-08-07 | A Robert D Bailey | EVP & Chief Legal Officer | A | +33,557 | — |
| 2026-08-07 | Yehia Hashad | EVP of R&D and CMO | A | +20,973 | — |
| 2026-08-07 | Luc Bonnefoy | President, Surgical | A | +16,778 | — |
| 2026-08-07 | Sam Eldessouky | EVP and CFO | A | +50,335 | — |
| 2026-08-07 | A Robert D Bailey | EVP & Chief Legal Officer | A | +33,557 | — |
| 2026-08-07 | Luc Bonnefoy | President, Surgical | A | +16,778 | — |
| 2026-08-07 | Frederick Munsch | SVP, Controller and CAO | A | +9,091 | — |
| 2026-08-07 | Sam Eldessouky | EVP and CFO | A | +50,335 | — |
| 2026-08-07 | Brent L Saunders | Chairman of the Board and CEO | MIXED | +277,648 | −$70.91K |
| 2026-08-07 | Andrew J. Stewart | President, GPIC | A | +16,778 | — |
| 2026-08-07 | Yehia Hashad | EVP of R&D and CMO | A | +20,973 | — |
| 2026-06-16 | Luc Bonnefoy | President, Surgical | F | −1,008 | −$15.20K |
| 2026-05-28 | Thomas W. Ross Sr. | Director | A | +15,842 | +$249.99K |
| 2026-05-28 | John Paulson | Director | A | +15,842 | +$249.99K |
| 2026-05-28 | Andrew C. Von Eschenbach | Director | A | +15,842 | +$249.99K |
| 2026-05-28 | Karen Ling | Director | A | +15,842 | +$249.99K |
| 2026-05-28 | Steven H Collis | Director | A | +15,842 | +$249.99K |
| 2026-05-28 | Sarah B Kavanagh | Director | A | +15,842 | +$249.99K |
| 2026-05-28 | Eduardo Alfonso | Director | A | +15,842 | +$249.99K |
| 2026-05-28 | Russel C Robertson | Director | A | +15,842 | +$249.99K |
| 2026-05-28 | Nathalie D. Bernier | Director | A | +15,842 | +$249.99K |
| 2026-05-26 | Brent L Saunders | Chairman of the Board and CEO | F | −2,886 | −$45.95K |
| 2026-05-07 | Luc Bonnefoy | President, Surgical | F | −11,970 | −$191.52K |
| 2026-05-07 | Sam Eldessouky | EVP and CFO | F | −63,938 | −$1.02M |
| 2026-05-07 | Frederick Munsch | SVP, Controller and CAO | F | −8,673 | −$138.77K |
| 2026-05-07 | Yehia Hashad | EVP of R&D and CMO | F | −13,664 | −$218.62K |
| 2026-05-01 | John Paulson | Director | A | +1,375 | +$21.86K |
| 2026-05-01 | Steven H Collis | Director | A | +1,415 | +$22.50K |
| 2026-05-01 | Russel C Robertson | Director | A | +1,611 | +$25.61K |
| 2026-05-01 | Eduardo Alfonso | Director | A | +1,375 | +$21.86K |
| 2026-04-27 | A Robert D Bailey | EVP & Chief Legal Officer | F | −15,806 | −$250.05K |
| 2026-04-27 | Andrew J. Stewart | President, GPIC | F | −4,216 | −$66.70K |
| 2026-03-10 | Sam Eldessouky | EVP and CFO | MIXED | +8,000 | +$68.52K |
| 2026-03-10 | A Robert D Bailey | EVP & Chief Legal Officer | MIXED | +29,200 | +$250.33K |
| 2026-03-10 | Brent L Saunders | CEO and Chairman of the Board | MIXED | +29,400 | +$251.96K |
| 2026-03-04 | Thomas W. Ross Sr. | Director | MIXED | +9,000 | +$79.56K |
| 2026-03-03 | Eduardo Alfonso | Director | MIXED | +8,600 | +$76.97K |
| 2026-03-03 | Andrew C. Von Eschenbach | Director | MIXED | +8,728 | +$79.88K |
| 2026-03-02 | Andrew J. Stewart | President, GPIC | F | −4,991 | −$91.90K |
| 2026-03-02 | Luc Bonnefoy | President, Surgical | F | −17,936 | −$329.07K |
| 2026-03-02 | Brent L Saunders | CEO and Chairman of the Board | F | −46,708 | −$858.95K |
| 2026-03-02 | A Robert D Bailey | EVP & Chief Legal Officer | F | −5,856 | −$107.81K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Brent L Saunders | Chairman of the Board and CEO | 974,158 | $16.97M |
| Sam Eldessouky | EVP and CFO | 393,527 | $6.86M |
| A Robert D Bailey | EVP & Chief Legal Officer | 264,241 | $4.60M |
| Yehia Hashad | EVP of R&D and CMO | 187,350 | $3.26M |
| Luc Bonnefoy | President, Surgical | 103,801 | $1.81M |
| Andrew J. Stewart | President, GPIC | 103,211 | $1.80M |
| Russel C Robertson | Director | 94,260 | $1.64M |
| John Paulson | Director | 89,823 | $1.56M |
| Nathalie D. Bernier | Director | 85,505 | $1.49M |
| Thomas W. Ross Sr. | Director | 85,233 | $1.48M |
| Sarah B Kavanagh | Director | 69,541 | $1.21M |
| Andrew C. Von Eschenbach | Director | 63,733 | $1.11M |
| Karen Ling | Director | 61,518 | $1.07M |
| Gaoxiang Hu | Director | 61,147 | $1.07M |
| Brett Icahn | Director | 61,147 | $1.07M |
| Frederick Munsch | SVP, Controller and CAO | 45,831 | $798.38K |
| Steven H Collis | Director | 42,003 | $731.69K |
| Eduardo Alfonso | Director | 31,072 | $541.27K |
| Barbara Trebbi | Director | 11,776 | $205.14K |
| Robert J Chersi | Director | 11,776 | $205.14K |
| Laurence E Paul | Director | 11,776 | $205.14K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the BLCO quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.